Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C

Author： Jansen Peter LM   De Bruijne Joep  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.1, 2012-01, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 977-980

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon- -2b in the treatment of acute hepatitis C

By  

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Interferon (IFN)- -2b is effective in patients with mild chronic hepatitis C

By  

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The Treatment of Chronic Hepatitis C not Responding to Interferon

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 967-975

Bentham Science Publishers

Access to resources Recommend Favorite

Albumin-interferon-α in the treatment of chronic hepatitis C

By Balan Vijayan  

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 269-278

Future Medicine

Access to resources Recommend Favorite